Safe CRISPR-Cas9 Inhibition of HIV-1 with High Specificity and Broad-Spectrum Activity by Targeting LTR NF-κB Binding Sites.
Mol Ther Nucleic Acids
; 21: 965-982, 2020 Sep 04.
Article
in En
| MEDLINE
| ID: mdl-32818921
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Prognostic_studies
Language:
En
Journal:
Mol Ther Nucleic Acids
Year:
2020
Document type:
Article
Affiliation country: